Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) shares were down 6.5% during mid-day trading on Wednesday . The company traded as low as $23.93 and last traded at $24.18. Approximately 90,930 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 242,660 shares. The stock had previously closed at […]
More Stories
Sysco (NYSE:SYY) Price Target Raised to $88.00
Sysco (NYSE:SYY – Free Report) had its price target increased by JPMorgan Chase & Co. from $85.00 to $88.00 in...
Trio-Tech International (NYSE:TRT) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Trio-Tech International (NYSE:TRT – Free Report) in a research report released on Monday morning....
SL Green Realty (NYSE:SLG) Upgraded to “Inline” by Evercore ISI
Evercore ISI upgraded shares of SL Green Realty (NYSE:SLG – Free Report) from an underperform rating to an inline rating...
StockNews.com Upgrades Trade Desk (NASDAQ:TTD) to “Buy”
StockNews.com upgraded shares of Trade Desk (NASDAQ:TTD – Free Report) from a hold rating to a buy rating in a...
Morgan Stanley Trims Range Resources (NYSE:RRC) Target Price to $31.00
Range Resources (NYSE:RRC – Free Report) had its price objective decreased by Morgan Stanley from $33.00 to $31.00 in a...
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report report...